Filing Details

Accession Number:
0001181431-12-002875
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-18 15:29:37
Reporting Period:
2012-01-13
Filing Date:
2012-01-18
Accepted Time:
2012-01-18 15:29:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198237 Phd P Alain Rolland 10390 Pacific Center Court
San Diego CA 92121
Exec Vp, Product Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2012-01-13 27,000 $0.01 171,563 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2012-01-13 29,875 $0.00 29,875 $3.67
Common Stock Nonstatutory Stock Option (right to buy) Acquisiton 2012-01-13 117,125 $0.00 117,125 $3.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
639,875 2013-01-13 2022-01-12 No 4 A Direct
757,000 2013-01-13 2022-01-12 No 4 A Direct
Footnotes
  1. Share were acquired pursuant to a restricted stock grant.
  2. The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
  3. This balance includes 105,750 of unvested restricted stock units.